M. E. Ivey

发表

Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.

Merlin C. Thomas, Merlin C Thomas, P. Little, 2005, Kidney international.

Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis.

P. Little, N. Osman, M. E. Ivey, 2008, Atherosclerosis.

Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.

P. Little, M. E. Ivey, 2008, Thrombosis research.

The effect of PPAR ligands to modulate glucose metabolism alters the incorporation of metabolic precursors into proteoglycans synthesized by human vascular smooth muscle cells

P. Little, J. Nigro, M. E. Ivey, 2008 .

Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.

P. Little, M. Ballinger, J. Nigro, 2007, Journal of diabetes and its complications.

Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis.

P. Little, N. Osman, M. E. Ivey, 2008, Current vascular pharmacology.

Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL.

P. Little, N. Osman, M. Ballinger, 2009, Atherosclerosis.

Actions of Calcium Channel Blockers on Vascular Proteoglycan Synthesis: Relationship to Atherosclerosis

P. Little, N. Osman, J. Nigro, 2005, Vascular health and risk management.

Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor-&ggr; Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation

G. Jennings, P. Little, D. Bruemmer, 2003, Circulation.